Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
about
Role of endothelin-1 in lung diseaseDual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney diseaseEndothelinEndothelin Blockade in Diabetic Kidney DiseaseAdipokines as a link between obesity and chronic kidney diseaseThe kallikrein-kinin system in diabetic nephropathyAnimal models of systemic sclerosis: their utility and limitations.Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the ratLack of an apparent role for endothelin-1 in the prolonged reduction in renal perfusion following severe unilateral ischemia-reperfusion injury in the mouse.Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic miceTransgenic animal models for the analysis of the renal endothelin system.A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis.Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival.Transgenic mice over-expressing ET-1 in the endothelial cells develop systemic hypertension with altered vascular reactivity.The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.Is there a role for endothelin antagonists in diabetic renal disease?Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension.Endothelin and endothelin antagonists in chronic kidney disease.Prevention of cultured rat stellate cell transformation and endothelin-B receptor upregulation by retinoic acid.The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivoRole of endothelins in animal models of hypertension: focus on cardiovascular protection.Endothelin-1 in chronic renal failure and hypertension.Cre recombinase-regulated Endothelin1 transgenic mouse lines: novel tools for analysis of embryonic and adult disorders.Endothelin and the podocyteEndothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 RatsAutoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.Progression and regression in renal vascular and glomerular fibrosis.The potential of endothelin antagonism as a therapeutic approach.Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.Renal phenotype of ET-1 transgenic mice is modulated by androgensThe role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights.Role of endothelin in fibrosis and anti-fibrotic potential of bosentan.Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.Hypertension, kidney, and transgenics: a fresh perspective.ET-1 actions in the kidney: evidence for sex differences.Endothelin-1 and the kidney--beyond BP.Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactionsEndothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species
P2860
Q24791936-E81ECC6A-6CE6-4C35-8B5B-70C752663591Q26752292-37A8920A-2152-4E8F-88ED-9ACF3FD9191CQ26767156-DB8EA03B-9DD9-4EB9-8C35-BFA8EE3CE8FBQ26799476-AD652C67-86A2-4DCF-BD5D-D6540C4FDB33Q26825339-553E871E-B78F-48FC-9C7D-2AE888405809Q26827473-18F0A589-6D1C-4A0E-AE62-15D9EC323617Q28390528-5BB97029-3868-4CA9-B89B-4D87EB2581A6Q28575856-D79929B5-22AD-4B20-AA38-91BDC53AAE59Q30369222-08EC6A92-1D29-4AB7-9EBE-87011DB72AD6Q33933352-12E86780-E2EB-4A27-BF73-7D33B62EBD71Q33947707-78AB546C-2642-4A73-8280-A29FD7682D9EQ33954012-AB081AD1-B20C-4EFF-BB58-FB9D2F9C5A21Q33975753-FC9B7515-D75F-434D-8ABF-E78A48327587Q34077735-3073D193-942B-4521-903C-956A8949F812Q34097210-541644A9-AE1B-4265-97DE-8936944141F3Q34163153-960FACC9-9F08-4845-80B5-147234A47469Q34213510-EA46C6E8-7B2D-4CEA-BC96-DD2F880CA68BQ34437692-D219C600-3D6B-4192-8310-1E4C9D1A7D34Q35045421-865634FF-714B-412C-A16A-CA5079255D28Q35046058-9407743B-FF67-42B5-B384-A80B49194024Q35168394-2F99F70E-E3DA-4DDC-858C-88A904BAEE93Q35168426-DA1E78CC-F6A1-42F8-8467-99FCDACBEA26Q35268488-3F67C2E4-4517-4059-BD66-692E312AE680Q35452282-E3A9C56D-8827-4FE6-81C7-CB58EEB430DFQ35596657-2E1893FF-7221-44F4-B9DF-574580DD28CCQ35660077-ABB46932-B139-4260-849D-C1BDE5C9C9BFQ35715914-0333AA0E-03C6-4EA6-864E-1051B7388059Q35758342-E3C5BEF5-5162-43D3-A709-36D7D7B39BD3Q35925573-C53A4FD0-466F-4CBD-BAD0-F8A26C846E47Q35938697-A31576BD-F476-4E60-9458-504E8BBBFC50Q35959010-460749B1-2403-418D-8FFE-B6961D711525Q36067020-1870D6A3-7870-4C9D-BBBD-0E7A4EB53616Q36132271-66FE8F83-16EC-4659-A2AC-816CC2F4447AQ36188436-0EE02EDA-F9BC-4219-82B7-47F51DD64679Q36297539-92359A6D-BF86-4842-A8F7-4040883878B6Q36443015-FCE0D072-E2F2-4788-ABAE-6A104F195AECQ36610325-5B5D11C7-28F4-4290-9114-1014AAD75D81Q36619734-ECC48567-4989-48B2-880F-B84141E85908Q36927753-FDA55B8A-00C2-4B27-8C9A-9835E7D10B5FQ37084544-751375AF-A311-4701-8976-2BBE28D79539
P2860
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelin-1 transgenic mice d ...... al cysts but not hypertension.
@en
Endothelin-1 transgenic mice d ...... al cysts but not hypertension.
@nl
type
label
Endothelin-1 transgenic mice d ...... al cysts but not hypertension.
@en
Endothelin-1 transgenic mice d ...... al cysts but not hypertension.
@nl
prefLabel
Endothelin-1 transgenic mice d ...... al cysts but not hypertension.
@en
Endothelin-1 transgenic mice d ...... al cysts but not hypertension.
@nl
P2093
P2860
P356
P1476
Endothelin-1 transgenic mice d ...... nal cysts but not hypertension
@en
P2093
Neumayer HH
Quertermous T
Rohmeiss P
Schleuning WD
Schmager F
Siegmund F
Slowinski T
Theuring F
P2860
P304
P356
10.1172/JCI119297
P407
P577
1997-03-01T00:00:00Z